Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.44 USD | 0.00% | -3.94% | -88.09% |
Apr. 03 | North American Morning Briefing : Powell Awaited -2- | DJ |
Apr. 02 | JMP Securities Upgrades AN2 Therapeutics to Market Outperform From Market Perform | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.09% | 72.78M | |
+24.67% | 46.71B | |
+48.83% | 41.8B | |
-1.02% | 41.52B | |
-5.86% | 29.55B | |
+10.86% | 25.78B | |
-20.48% | 19.26B | |
+2.40% | 12.14B | |
-2.71% | 12.08B | |
+28.38% | 11.98B |
- Stock Market
- Equities
- ANTX Stock
- News AN2 Therapeutics, Inc.
- AN2 Therapeutics Shares Plunge Pre-Bell After Pausing Phase 3 Enrollment in Lung Disease Drug Trial